Central nervous system disorders

Search pages

Print

CENTRAL NERVOUS SYSTEM DISORDER programs

Nalmefene

Biotie’s nalmefene is an opioid receptor antagonist that is being developed for the treatment of alcohol dependence.

Read more

Phosphodiesterase 10 (PDE10) inhibitors, a novel treatment paradigm for Schizophrenia

PDE10 is a novel molecular target and Biotie has shown antipsychotic activity of PDE10 inhibitors in animal models. Biotie’s PDE10 inhibitors are believed to serve the unmet medical need for novel anti-psychotic drugs with an improved side effect profile and improved efficacy in schizophrenia.